secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2023-03-06T23:59:59+00:00
Accession:  0000950170-23-006239
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix reports Q4 2022 results; SeaSpine merger closed Jan 5; combined 2023 guidance $743-753M
--------------------------------------------------------------------------------

- Orthofix stand-alone Q4 net sales $122.2M (-2% reported, flat constant currency); net loss $7.1M vs $32.8M loss prior year.
- SeaSpine stand-alone Q4 net sales $63.4M (+14% YoY); net loss $19.0M vs $18.8M loss prior year.
- Combined company expects Q1 2023 net sales $166-170M and full-year 2023 net sales $743-753M.
- Merger of Orthofix and SeaSpine completed January 5, 2023; results do not include merger accounting adjustments.
- Orthofix borrowed $45M under credit facility in Jan/Mar 2023 to fund merger expenses and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000095017023006239/0000950170-23-006239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000095017023006239/ofix-20230306.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-006239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer